---
title: "InnoCare Pharma (688428.SH) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688428.SH/norm.md"
symbol: "688428.SH"
name: "InnoCare Pharma"
parent: "https://longbridge.com/en/quote/688428.SH.md"
datetime: "2026-05-20T19:27:32.195Z"
locales:
  - [en](https://longbridge.com/en/quote/688428.SH/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688428.SH/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688428.SH/norm.md)
---

# InnoCare Pharma (688428.SH) — Financial Reports

## Income Statement (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.0600 | 0.3659 | -0.0188 | -0.0396 | 0.0100 |
| ROE | 5.62% | 39.29% | -2.05% | -2.86% | 1.07% |
| Revenue | 528.63M | 1.26B | 383.89M | 350.17M | 381.26M |
| Net income | 105.82M | 706.88M | -34.32M | -48.06M | 17.97M |
| Operating income | 73.81M | 633.39M | -52.79M | -108.29M | -20.01M |
| Gross margin | 88.14% | 94.75% | 87.38% | 88.39% | 90.54% |
| Net margin | 20.02% | 56.12% | -8.94% | -13.72% | 4.71% |
| Profit quality | 1748.98% | 376.48% | - | - | -35.41% |

## Balance Sheet (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 10.38B | 10.82B | 9.52B | 9.36B | 9.41B |
| Leverage | 1.41 | 1.40 | 1.43 | 1.39 | 1.39 |
| BVPS | 4.16 | 4.00 | 3.66 | 5.53 | 3.76 |
| Turnover | 0.2548 | 0.2348 | 0.1504 | 0.1388 | 0.1277 |
| Cash & STI | 7.09B | 7.07B | 7.02B | 7.06B | 7.01B |
| Inv & Rec | 174.13M | 162.87M | 125.26M | 117.75M | 97.07M |
| LT assets | 729.47M | 752.26M | 755.03M | 775.40M | 797.07M |
| Net debt | -5.28B | -5.46B | -5.36B | -5.52B | -5.46B |

## Cash Flow Statement (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 4.22M | 168.24M | -22.52M | -118.34M | 56.52M |
| Investing CF | -506.84M | 74.49M | -383.80M | -15.93M | 78.22M |
| Financing CF | 183.32M | -85.50M | 109.88M | -4.42M | 32.75M |
| Free CF | -231.77M | 679.36M | -248.48M | 132.11M | -88.69M |
| OCF coverage | 2.07% | 124.03% | -40.94% | -279.68% | 42.13% |
| Repaid & issued | 372.47M | 2.16M | 175.53M | 4.04M | 79.20M |
| CapEx | -20.04M | -31.67M | -13.56M | -9.87M | -15.06M |